Selected research
Market Structure
Global Flutamide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Flutamide market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Flutamide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Flutamide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Flutamide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Flutamide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Flutamide include Tasly Diyi Pharma, Forward, SANDOZ, Merck, TEVA Pharma, Florencia Healthcare, Cipla LifeScience and Actiza Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Flutamide market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Flutamide and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Flutamide sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Flutamide market size, projected growth trends, production technologies, key applications, and end-use industries.
Flutamide Segment by Company
Tasly Diyi Pharma
Forward
SANDOZ
Merck
TEVA Pharma
Florencia Healthcare
Cipla LifeScience
Actiza Pharma
Flutamide Segment by Type
Flutamide Tablets
Flutamide Capsule
Others
Flutamide Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Flutamide Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Flutamide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Flutamide and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Flutamide.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Flutamide market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Flutamide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Flutamide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Flutamide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Flutamide Tablets
- Flutamide Capsule
- Others
Applications
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
Companies covered
- Tasly Diyi Pharma
- Forward
- SANDOZ
- Merck
- TEVA Pharma
- Florencia Healthcare
- Cipla LifeScience
- Actiza Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Flutamide Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Flutamide Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Flutamide Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Flutamide Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Flutamide Market Dynamics
- 2.1 Flutamide Industry Trends
- 2.2 Flutamide Industry Drivers
- 2.3 Flutamide Industry Opportunities and Challenges
- 2.4 Flutamide Industry Restraints
3 Flutamide Market by Manufacturers
- 3.1 Global Flutamide Revenue by Manufacturers (2021-2026)
- 3.2 Global Flutamide Sales by Manufacturers (2021-2026)
- 3.3 Global Flutamide Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Flutamide Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Flutamide Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Flutamide Manufacturers, Product Type & Application
- 3.7 Global Flutamide Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Flutamide Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Flutamide Players Market Share by Revenue in 2025
- 3.8.3 2025 Flutamide Tier 1, Tier 2, and Tier 3
4 Flutamide Market by Type
- 4.1 Flutamide Type Introduction
- 4.1.1 Flutamide Tablets
- 4.1.2 Flutamide Capsule
- 4.1.3 Others
- 4.2 Global Flutamide Sales by Type
- 4.2.1 Global Flutamide Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Flutamide Sales by Type (2021-2032)
- 4.2.3 Global Flutamide Sales Market Share by Type (2021-2032)
- 4.3 Global Flutamide Revenue by Type
- 4.3.1 Global Flutamide Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Flutamide Revenue by Type (2021-2032)
- 4.3.3 Global Flutamide Revenue Market Share by Type (2021-2032)
5 Flutamide Market by Application
- 5.1 Flutamide Application Introduction
- 5.1.1 Hospital Pharmacies
- 5.1.2 Online Pharmacies
- 5.1.3 Retail Pharmacies
- 5.2 Global Flutamide Sales by Application
- 5.2.1 Global Flutamide Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Flutamide Sales by Application (2021-2032)
- 5.2.3 Global Flutamide Sales Market Share by Application (2021-2032)
- 5.3 Global Flutamide Revenue by Application
- 5.3.1 Global Flutamide Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Flutamide Revenue by Application (2021-2032)
- 5.3.3 Global Flutamide Revenue Market Share by Application (2021-2032)
6 Global Flutamide Sales by Region
- 6.1 Global Flutamide Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Flutamide Sales by Region (2021-2032)
- 6.2.1 Global Flutamide Sales by Region (2021-2026)
- 6.2.2 Global Flutamide Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Flutamide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Flutamide Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Flutamide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Flutamide Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Flutamide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Flutamide Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Flutamide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Flutamide Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Flutamide Revenue by Region
- 7.1 Global Flutamide Revenue by Region
- 7.1.1 Global Flutamide Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Flutamide Revenue by Region (2021-2026)
- 7.1.3 Global Flutamide Revenue by Region (2027-2032)
- 7.1.4 Global Flutamide Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Flutamide Revenue (2021-2032)
- 7.2.2 North America Flutamide Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Flutamide Revenue (2021-2032)
- 7.3.2 Europe Flutamide Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Flutamide Revenue (2021-2032)
- 7.4.2 Asia-Pacific Flutamide Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Flutamide Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Flutamide Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Tasly Diyi Pharma
- 8.1.1 Tasly Diyi Pharma Company Information
- 8.1.2 Tasly Diyi Pharma Business Overview
- 8.1.3 Tasly Diyi Pharma Flutamide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Tasly Diyi Pharma Flutamide Product Portfolio
- 8.1.5 Tasly Diyi Pharma Recent Developments
- 8.2 Forward
- 8.2.1 Forward Company Information
- 8.2.2 Forward Business Overview
- 8.2.3 Forward Flutamide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Forward Flutamide Product Portfolio
- 8.2.5 Forward Recent Developments
- 8.3 SANDOZ
- 8.3.1 SANDOZ Company Information
- 8.3.2 SANDOZ Business Overview
- 8.3.3 SANDOZ Flutamide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 SANDOZ Flutamide Product Portfolio
- 8.3.5 SANDOZ Recent Developments
- 8.4 Merck
- 8.4.1 Merck Company Information
- 8.4.2 Merck Business Overview
- 8.4.3 Merck Flutamide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Merck Flutamide Product Portfolio
- 8.4.5 Merck Recent Developments
- 8.5 TEVA Pharma
- 8.5.1 TEVA Pharma Company Information
- 8.5.2 TEVA Pharma Business Overview
- 8.5.3 TEVA Pharma Flutamide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 TEVA Pharma Flutamide Product Portfolio
- 8.5.5 TEVA Pharma Recent Developments
- 8.6 Florencia Healthcare
- 8.6.1 Florencia Healthcare Company Information
- 8.6.2 Florencia Healthcare Business Overview
- 8.6.3 Florencia Healthcare Flutamide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Florencia Healthcare Flutamide Product Portfolio
- 8.6.5 Florencia Healthcare Recent Developments
- 8.7 Cipla LifeScience
- 8.7.1 Cipla LifeScience Company Information
- 8.7.2 Cipla LifeScience Business Overview
- 8.7.3 Cipla LifeScience Flutamide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Cipla LifeScience Flutamide Product Portfolio
- 8.7.5 Cipla LifeScience Recent Developments
- 8.8 Actiza Pharma
- 8.8.1 Actiza Pharma Company Information
- 8.8.2 Actiza Pharma Business Overview
- 8.8.3 Actiza Pharma Flutamide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Actiza Pharma Flutamide Product Portfolio
- 8.8.5 Actiza Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Flutamide Value Chain Analysis
- 9.1.1 Flutamide Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Flutamide Production Mode & Process
- 9.2 Flutamide Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Flutamide Distributors
- 9.2.3 Flutamide Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst